| Literature DB >> 20352048 |
Abstract
BACKGROUND: The contents of pharmaceutical industry sponsored supplements to medical journals are perceived to be less credible than the contents of their parent journals. It is unknown if their contents are cited as often. The objective of this study was to quantify the citability of original research and reviews contained in supplements and compare it with that for the parent journal. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2010 PMID: 20352048 PMCID: PMC2844430 DOI: 10.1371/journal.pone.0009876
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow Diagram of Articles in Each Cohort.
Citation counts for articles contained in the Journal of Clinical Psychiatry and supplements, 2000 and 2005.
| Year | Citations per Article | |||||||
| 2000 Cohort | 2005 Cohort | |||||||
| Parent Journal (N = 114 in 12 issues) | Supplements (N = 90 in 14 issues) | Parent Journal (N = 190 in 12 issues) | Supplements (N = 52 in 10 issues) | |||||
| median, range | mean ± SD | median, range | mean ± SD | median, range | mean ± SD | median, range | mean ± SD | |
| 2000 | 0, 0–4 | 0.52±.96 | 0, 0–6 | 0.83±1.17 | – | – | – | – |
| 2001 | 2, 0–21 | 3.05±3.25 | 3, 0–14 | 3.40±2.99 | – | – | – | – |
| 2002 | 3.5, 0–50 | 5.29±6.59 | 6, 0–20 | 5.80±3.78 | – | – | – | – |
| 2003 | 3.5, 0–50 | 5.89±6.76 | 6, 0–16 | 6.04±3.97 | – | – | – | – |
| 2004 | 4, 0–37 | 5.27±6.10 | 4.5, 0–28 | 5.63±4.68 | – | – | – | – |
| 2005 | 3, 0–32 | 5.26±5.89 | 5, 0–33 | 5.27±4.62 | 0, 0–11 | 0.73±1.53 | 0, 0–5 | 0.79±1.13 |
| 2006 | 3, 0–26 | 4.68±4.55 | 4, 0–26 | 4.34±4.00 | 3, 0–25 | 4.82±4.70 | 3, 0–16 | 3.64±3.06 |
| 2007 | 3, 0–23 | 4.06±4.46 | 3. 0–31 | 4.46±4.60 | 5, 0–40 | 6.52±6.49 | 4, 0–19 | 6.00±4.64 |
| 2008 | 2, 0–24 | 4.00±4.80 | 3, 0–39 | 4.12±5.36 | 5, 0–30 | 6.72±6.06 | 5, 0–42 | 6.54±6.33 |
| 2009 | 2, 0–12 | 2.41±2.54 | 1.5, 0–18 | 2.31±2.85 | 3, 0–25 | 4.16±4.42 | 3, 0–38 | 3.83±5.69 |
| All years | 27.5, 0–264 | 40.44±39.33 | 39, 4–206 | 42.21±29.62 | 16.5, 0–111 | 22.94±19.80 | 16, 2–100 | 20.79±16.55 |
| 3 years post-publication | 10, 0–116 | 14.22±15.42 | 14, 1–49 | 15.24±8.86 | 13.5, 0–85 | 18.05±15.44 | 13.5, 2–62 | 16.17±11.78 |
To October 5, 2009.
2001–2003 for the cohorts from 2000; 2006–2008 for the cohorts from 2005.
Nonparametric analyses of citation counts for the first 3 complete calendar years post-publication a b.
| Comparison | z-score | p-value |
| Parent journal vs supplements, 2000 cohorts | 2.309 | .02 |
| Parent journal vs supplements, 2005 cohorts | .145 | .88 |
| Parent journal, 2000 vs 2005 | 2.679 | .007 |
| Supplements, 2000 vs 2005 | .074 | .94 |
2001–2003 for the cohorts from 2000; 2006–2008 for the cohorts from 2005.
As calculated at http://www.socr.ucla.edu/htmls/ana/TwoIndependentSampleWilcoxonRankSum_Analysis.html; 2-tail p-value provided.
Proportion of articles that have generated ≥25 and ≥40 citations during the first 3 complete calendar years post-publication a.
| Category | Proportion | |||||||||
| 2000 Cohort | 2005 Cohort | |||||||||
| Parent Journal (N = 114 in 12 issues) | Supplements (N = 90 in 14 issues) | p-value | Parent Journal (N = 190 in 12 issues) | Supplements (N = 52 in 10 issues) | p-value | |||||
| n | % | n | % | n | % | n | % | |||
| ≥25 citations | 14 | 12.3% | 13 | 14.4% | 0.80 | 45 | 23.7% | 8 | 15.4% | .27 |
| ≥40 citations | 4 | 3.5% | 1 | 1.1% | 0.53 | 20 | 10.5% | 2 | 3.8% | .21 |
2001–2003 for the cohorts from 2000; 2006–2008 for the cohorts from 2005.
Fisher's exact test (as calculated at http://www.openepi.com/Menu/OpenEpiMenu.htm); 2-tail p-value provided.